Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02974803
Title Concurrent Dabrafenib + Trametinib With Sterotactic Radiation in BRAF Mutation-Positive Malignant Melanoma and Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Canadian Cancer Trials Group
Indications

melanoma

Therapies

Dabrafenib + Trametinib

Age Groups: senior | adult
Covered Countries CAN

Facility Status City State Zip Country Details
QEII Health Sciences Centre Halifax Nova Scotia B3H 1V7 Canada Details
Juravinski Cancer Centre at Hamilton Health Sciences Hamilton Ontario L8V 5C2 Canada Details
Odette Cancer Centre Toronto Ontario M4N 3M5 Canada Details
University Health Network Toronto Ontario M5G 2M9 Canada Details
Centre hospitalier universitaire de Sherbrooke Sherbrooke Quebec J1H 5N4 Canada Details
Saskatoon Cancer Centre Saskatoon Saskatchewan S7N 4H4 Canada Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field